ALAS1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.501050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.184600E-01
Normal-vs-Stage2
1.229160E-01
Normal-vs-Stage3
6.678400E-01
Normal-vs-Stage4
8.582300E-02
Stage1-vs-Stage2
6.765400E-01
Stage1-vs-Stage3
4.575400E-01
Stage1-vs-Stage4
2.367200E-01
Stage2-vs-Stage3
1.851560E-01
Stage2-vs-Stage4
1.211570E-01
Stage3-vs-Stage4
9.935700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.726560E-01
Normal-vs-AfricanAmerican
1.713780E-01
Normal-vs-Asian
1.013770E-01
Caucasian-vs-AfricanAmerican
9.377600E-01
Caucasian-vs-Asian
7.721200E-01
AfricanAmerican-vs-Asian
8.945400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.763440E-01
Normal-vs-Female
1.339170E-01
Male-vs-Female
8.966400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.921200E-01
Normal-vs-Age(41-60Yrs)
1.250650E-01
Normal-vs-Age(61-80Yrs)
1.592050E-01
Normal-vs-Age(81-100Yrs)
1.452780E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.781600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.058200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.784600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.874200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.676000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.398500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.411000E-01
Normal-vs-Daily Drinker
2.583200E-01
Normal-vs-Weekly Drinker
1.353610E-01
Normal-vs-Occasional Drinker
1.274360E-01
Normal-vs-Social Drinker
1.669760E-01
Non Drinker-vs-Daily Drinker
9.848200E-01
Non Drinker-vs-Weekly Drinker
4.734200E-01
Non Drinker-vs-Occasional Drinker
7.550200E-01
Non Drinker-vs-Social Drinker
5.277600E-01
Daily Drinker-vs-Weekly Drinker
5.143600E-01
Daily Drinker-vs-Occasional Drinker
7.845200E-01
Daily Drinker-vs-Social Drinker
5.688200E-01
Weekly Drinker-vs-Occasional Drinker
6.529800E-01
Weekly Drinker-vs-Social Drinker
9.401000E-01
Occasional Drinker-vs-Social Drinker
7.222800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.671600E-01
Normal-vs-Grade 2
1.847150E-01
Normal-vs-Grade 3
1.385400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.166300E-02
Grade 1-vs-Grade 3
6.275900E-02
Grade 1-vs-Grade 4
4.671600E-01
Grade 2-vs-Grade 3
6.562000E-01
Grade 2-vs-Grade 4
1.847150E-01
Grade 3-vs-Grade 4
1.385400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.331000E-01
Normal-vs-NonDiabetic
1.648840E-01
Diabetic-vs-NonDiabetic
6.067000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.359000E-01
Normal-vs-NoPancreatitis
1.691450E-01
Pancreatitis-vs-NoPancreatitis
3.362800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.318840E-01
Normal-vs-N1
1.416960E-01
N0-vs-N1
9.964600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.234820E-01
Normal-vs-TP53-NonMutant
4.107800E-01
TP53-Mutant-vs-TP53-NonMutant
9.592400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
